Company news
Pulmonx Corporation news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Pulmonx Reports Third Quarter 2022 Financial Results
November 2, 2022
Pulmonx to Report Third Quarter 2022 Financial Results on November 3, 2022
October 19, 2022
Pulmonx Reports Second Quarter 2022 Financial Results
August 1, 2022
Pulmonx to Report Second Quarter 2022 Financial Results on August 2, 2022
July 18, 2022
Pulmonx Reports First Quarter 2022 Financial Results
May 2, 2022
Pulmonx to Report First Quarter 2022 Financial Results on May 3, 2022
April 18, 2022
Pulmonx Reports Fourth Quarter and Full Year 2021 Financial Results
February 22, 2022
Pulmonx Reports Third Quarter 2021 Financial Results
November 1, 2021
Pulmonx to Report Third Quarter 2021 Financial Results on November 2, 2021
October 25, 2021
Pulmonx Announces Two Additional Significant Blue Cross Blue Shield Plans Now Provide Coverage for Severe Emphysema/COPD Treatment
September 20, 2021
Pulmonx Announces Anthem Blue Cross Blue Shield Now Provides Coverage for Severe COPD/Emphysema Treatment
August 19, 2021
Pulmonx Reports Second Quarter 2021 Financial Results
August 2, 2021
Pulmonx Welcomes Two New Board Members, Adding Expertise in Health Technology, Consumer Marketing, and Integrated Healthcare Delivery Networks
August 1, 2021
Pulmonx Announces Long-Term Follow-Up Data Confirming Significant Benefits of Zephyr Valve for Patients with Severe COPD/Emphysema
July 26, 2021
Pulmonx to Report Second Quarter 2021 Financial Results on August 3, 2021
July 19, 2021
Pulmonx Reports First Quarter 2021 Financial Results
May 3, 2021
Pulmonx Corporation Expands Leadership Team
May 3, 2021
Pulmonx to Report First Quarter 2021 Financial Results on May 4, 2021
April 19, 2021
Pulmonx Reports Fourth Quarter and Full Year 2020 Financial Results
March 1, 2021
Pulmonx to Report Fourth Quarter and Full Year 2020 Financial Results on March 2, 2021
February 15, 2021
Pulmonx Welcomes Two New Members to Its Board of Directors, Adding Expertise in Consumer Marketing and Medical Device Company Growth
December 7, 2020
Pulmonx Reports Third Quarter 2020 Financial Results
November 9, 2020
Pulmonx Announces Additional 16 Million Covered Lives for The Zephyr® Valve, a Minimally Invasive Treatment Option for Severe Emphysema (COPD)
November 1, 2020
Pulmonx to Report Third Quarter 2020 Financial Results on November 10, 2020
October 21, 2020
Pulmonx Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
October 4, 2020
Calls
The 5 newest of 25 calls. Every call is listed under its year.
- Pulmonx (NASDAQ:LUNG) Q3 2026 Earnings Call
Oct 27, 2026
Transcript - Pulmonx (NASDAQ:LUNG) Q2 2026 Earnings Call
Jul 29, 2026
Transcript - Pulmonx (NASDAQ:LUNG) Q1 2026 Earnings Call
Apr 29, 2026
Transcript - Pulmonx (NASDAQ:LUNG) Q4 2025 Earnings Call
Mar 4, 2026
Transcript - Pulmonx (NASDAQ:LUNG) Q3 2025 Earnings Call
Nov 12, 2025
Transcript
Decks
- Investor Presentation (July 2026)
Investor deck · 21 slides · July 2026